Grown Rogue International (GRUSF) Income towards Parent Company (2009 - 2026)

Grown Rogue International's (GRUSF) quarterly Income towards Parent Company came in at -$2.2 million in Q1 2026, down 320.16% year-on-year from $1.0 million in Q1 2025, and up 100.0% quarter-over-quarter from -$5914.4 billion in Q4 2025.

Grown Rogue International (GRUSF) Income towards Parent Company (2009 - 2026) Analysis & Trends

Grown Rogue International's Income towards Parent Company history runs 18 years deep, the most recent figure standing at -$2.2 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company fell 320.16% year-over-year to -$2.2 million in Q1 2026; TTM through Mar 2026 was -$3216.1 billion, a 302.76% decrease from a year earlier, with the FY2025 full-year figure at -$2.1 million, up 81.27% from the prior year.
  • Income towards Parent Company advanced to -$2.2 million in Q1 2026 per GRUSF's latest filing, from -$5914.4 billion in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $2698.3 billion in Q3 2025 and bottomed at -$5914.4 billion in Q4 2025.
  • The 5-year median for Income towards Parent Company is -$4989.0 (2022), against an average of -$286.8 billion.
  • Across the five-year window, Income towards Parent Company jumped 437.92% in 2025 and plunged 320.16% in 2026, its largest moves.
  • Year by year, Income towards Parent Company stood at -$422824.0 in 2022, then jumped by 252.03% to $642820.0 in 2023, then plunged by 124220877.2% to -$798.5 billion in 2024, then slumped by 640.68% to -$5914.4 billion in 2025, then surged by 100.0% to -$2.2 million in 2026.
  • Per Business Quant, the three latest GRUSF Income towards Parent Company figures stand at -$2.2 million (Q1 2026), -$5914.4 billion (Q4 2025), and $2698.3 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Grown Rogue International 99.32 Mn 85.61 Mn 3.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.21 Mn
Dec 31, 2025 -5,914.43 Bn
Sep 30, 2025 2,698.31 Bn
Jun 30, 2025 1.32 Mn
Mar 31, 2025 1.01 Mn
Sep 30, 2024 -798.52 Bn
Jun 30, 2024 -5.62 Mn
Mar 31, 2024 -4.20 Mn
Dec 31, 2023 642,820.00
Oct 31, 2023 -1.47 Mn
Jul 31, 2023 640,713.00
Apr 30, 2023 412,846.00
Jan 31, 2023 931,945.00
Jan 31, 2022 -422,824.00
Jul 31, 2021 -54,533.00
Apr 30, 2021 -1.43 Mn
Jan 31, 2021 -1.08 Mn
Oct 31, 2020 26,352.00
Jul 31, 2020 -798,200.00
Apr 30, 2020 -1.28 Mn